Nature Communications (Oct 2022)
Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer
Abstract
Infection is a major issue in chronic diabetic wounds. Here, the authors report on a hypoxia triggered drug delivery system to achieve higher drug levels with controlled release to treat wounds infected with multidrug-resistant pseudomonas aeruginosa and demonstrate antibacterial and anti-biofilm action